SpicyIP Weekly Review (November 13- November 19)
SpicyIP
NOVEMBER 19, 2023
The issue here pertains to the question of whether a patent office located in one place can transfer a patent application to another office in the absence of any specific provision in the law. Novartis’s blockbuster drug “Tasigna” faces a decline in the sales as patent term nears to end in January 2024.
Let's personalize your content